Here’s How Much You Would Have Made Owning MicroStrategy Stock In The Last 20 Years

MicroStrategy (NASDAQ:MSTR) has outperformed the market over the past 20 years by 4.33% on an annualized basis producing…

MicroStrategy (NASDAQ:MSTR) has outperformed the market over the past 20 years by 4.33% on an annualized basis producing an average annual return of 11.93%. Currently, MicroStrategy has a market capitalization of $2.00 billion.

Buying $100 In MSTR: If an investor had bought $100 of MSTR stock 20 years ago, it would be worth $902.25 today based on a price of $176.39 for MSTR at the time of writing.

MicroStrategy’s Performance Over Last 20 Years

comp_fig

Finally — what’s the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

AstraZeneca Announced Enhertu Showed Clinically Meaningful And Durable Responses Across Multiple HER2-Expressing Tumor Types In DESTINY-PanTumor02 Phase II Trial

Positive high-level results from an analysis of the ongoing DESTINY-PanTumor02 Phase II trial showed AstraZeneca and Daiichi Sankyo's Enhertu (trastuzumab deruxtecan) met the prespecified target for objective response rate (ORR) and demonstrated durable response across multiple HER2-expressing advanced solid tumours in heavily pretreated patients.

AZN